To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DHTKD1andSEC61A2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
521 supporting clones for gene DHTKD1andSEC61A2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CF593518 Human Placenta, placenta .a 1 to 798 31 to 837   tiling clone,   807/883
(91 %)
23 diff
(97.4 %id)
NM_018706.5   .a 1 to 5202 1 to 5202 F20L RefSeq,   5202/5202
(100 %)
8 diff
(99.9 %id)
BP225257   .a 18 to 599 1 to 582       582/582
(100 %)
8 diff
(98.7 %id)
BP313732 mammary gland .a 19 to 600 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
CF994488 Human Placenta, placenta .a 20 to 788 28 to 809       782/850
(92 %)
19 diff
(97.8 %id)
DB232998 trachea .a 21 to 479 2 to 461   capped   460/460
(100 %)
2 diff
(99.6 %id)
DB478431 hippocampus .a 23 to 471 1 to 449       449/449
(100 %)
2 diff
(99.6 %id)
CD656300 Embryonic Stem cells .a 35 to 875 5 to 833       831/833
(99 %)
23 diff
(97.3 %id)
DN997291 breast cancer, Mammary gland (cancer tissue) .a 35 to 799 1 to 765       765/765
(100 %)
6 diff
(99.3 %id)
BC002477 Kidney, renal cell adenocarcinoma .a 38 to 3190 1 to 3153 F20L Y272D R308L I607M tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3153/3153
(100 %)
7 diff
(99.8 %id)
CN483812 eye .a 38 to 668 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
BQ232102 melanotic melanoma, skin .a 38 to 813 1 to 778       778/866
(89 %)
6 diff
(99.4 %id)
BE272798 Kidney, renal cell adenocarcinoma .a 41 to 753 39 to 752       714/832
(85 %)
32 diff
(96.2 %id)
CN360006 embryonic stem cells, DMSO-treated H9 cellline .a 48 to 766 7 to 726       720/726
(99 %)
2 diff
(99.8 %id)
BF685424 leiomyosarcoma cell line, uterus .a 55 to 798 1 to 739       739/840
(87 %)
26 diff
(97.0 %id)
BC007955 Uterus, leiomyosarcoma .a 56 to 3190 1 to 3135 F20L tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3135/3135
(100 %)
4 diff
(99.9 %id)
CN360005 embryonic stem cells, cell lines H1, H7, andH9 .a 65 to 766 25 to 727       703/728
(96 %)
8 diff
(99.0 %id)
AL553339 placenta, Placenta Cot 25-normalized .a 82 to 1101 1 to 1018       1018/1083
(93 %)
16 diff
(98.6 %id)
TI_1948149552   .a 94 to 1083 134 to 1118   AAA   985/1364
(72 %)
51 diff
(96.3 %id)
TI_1948149845   .a 94 to 1000 129 to 1030       902/1349
(66 %)
24 diff
(98.3 %id)
AL556890 placenta .a 108 to 1049 1 to 941       941/941
(100 %)
6 diff
(99.4 %id)
AA120828 Pancreas .a 295 to 420 1 to 126       126/128
(98 %)
1 diff
(99.3 %id)
CR749726 melanoma (MeWo cell line) .a 1235 to 3191 1 to 1957   available from DKFZ, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1957/1958
(99 %)
6 diff
(99.7 %id)
AA179447   .a 1476 to 1933 1 to 459       459/459
(100 %)
9 diff
(98.1 %id)
TI_1948150441   .a 1792 to 2858 1203 to 130       1074/1352
(79 %)
35 diff
(97.5 %id)
TI_1948150138   .a 1836 to 2858 1145 to 131       1015/1312
(77 %)
63 diff
(95.2 %id)
TI_1948150442   .a 1853 to 2858 1127 to 130       998/1313
(76 %)
30 diff
(97.8 %id)
TI_1948150137   .a 1889 to 2858 1093 to 127       967/1305
(74 %)
16 diff
(98.8 %id)
TI_1948149553   .a 1923 to 2858 1069 to 128       942/1350
(69 %)
26 diff
(98.1 %id)
TI_1948149846   .a 1994 to 2858 999 to 130   tiling clone,   870/1327
(65 %)
22 diff
(98.4 %id)
AL553309 placenta, Placenta Cot 25-normalized .a 2139 to 3154 1013 to 1       1013/1015
(99 %)
17 diff
(98.4 %id)
AL579044 placenta .a 2145 to 3152 1008 to 1       1008/1008
(100 %)
1 diff
(100.0 %id)
AL579012 placenta .a 2154 to 3155 997 to 1       997/997
(100 %)
14 diff
(98.6 %id)
TI_1948150402   .a 2246 to 2863 752 to 125       628/1447
(43 %)
63 diff
(95.7 %id)
TI_1948150401   .a 2251 to 2863 743 to 126       618/1479
(41 %)
30 diff
(98.0 %id)
BF345833 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2297 to 2769 1 to 469       469/469
(100 %)
6 diff
(98.8 %id)
BF970856 adrenal cortex carcinoma, cell line, adrenal gland .a 2403 to 2769 1 to 367       367/367
(100 %)
0 diff
(100 %id)
BQ375163 testis_normal .a 2507 to 2825 329 to 3       323/329
(98 %)
18 diff
(94.6 %id)
BQ348546 head_neck .a 2525 to 2791 1 to 267       267/277
(96 %)
2 diff
(99.3 %id)
BE300819 choriocarcinoma, placenta .a 2578 to 3028 462 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 452/452
(100 %)
6 diff
(98.7 %id)
CD629460   .a 2605 to 2886 278 to 1       282/278
(101 %)
17 diff
(93.9 %id)
TI_59393647   .a 2633 to 3207 96 to 670       575/813
(70 %)
4 diff
(99.6 %id)
BM015412 breast, mammary adenocarcinoma, cell line .a 2634 to 2769 1 to 136       136/136
(100 %)
0 diff
(100 %id)
BI868174 adenocarcinoma, cell line, Liver .a 2640 to 2769 1 to 130       130/130
(100 %)
0 diff
(100 %id)
TI_57227827   .a 2640 to 3234 55 to 656       602/758
(79 %)
18 diff
(97.7 %id)
AA179304   .a 2670 to 3164 493 to 1       493/499
(98 %)
2 diff
(99.6 %id)
AW978949   .a 2673 to 3189 513 to 1     Submitted on the opposite strand 513/517
(99 %)
7 diff
(98.7 %id)
BE206420 adenocarcinoma cell line, ovary .a 2677 to 3193 517 to 1       517/517
(100 %)
10 diff
(98.1 %id)
BU165563 eye, retinoblastoma .a 2688 to 3188 12 to 512   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 501/513
(97 %)
11 diff
(97.9 %id)
AA857360 pharynx, squamous cell carcinoma .a 2694 to 3190 494 to 1       495/494
(100 %)
11 diff
(97.8 %id)
AA827875 germinal center B cell .a 2705 to 3197 492 to 1       492/492
(100 %)
1 diff
(99.8 %id)
AA910941 Kidney .a 2729 to 3155 425 to 1       425/425
(100 %)
2 diff
(99.6 %id)
AI354330 esophagus, squamous cell carcinoma .a 2739 to 3194 457 to 1       457/457
(100 %)
2 diff
(99.6 %id)
AA629581 lung, lung carcinoma .a 2751 to 3164 412 to 1       412/412
(100 %)
13 diff
(96.9 %id)
DB547082 hippocampus .a 2766 to 3190 1 to 425     Submitted on the opposite strand 425/425
(100 %)
0 diff
(100 %id)
AI720403 colon .a 2786 to 3193 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA120829 Pancreas .a 2798 to 3164 375 to 1       375/409
(91 %)
10 diff
(97.6 %id)
AI247101 adenocarcinoma, Pancreas .a 2855 to 3206 350 to 1       350/350
(100 %)
7 diff
(98.0 %id)
BU532617 mixed (pool of 40 RNAs) .a 2914 to 3417 1 to 507       507/537
(94 %)
1 diff
(99.9 %id)
BU927608 mixed (pool of 40 RNAs) .a 2914 to 3428 1 to 516       516/553
(93 %)
6 diff
(99.0 %id)
BU939822 mixed (pool of 40 RNAs) .a 2914 to 3332 1 to 430       430/891
(48 %)
16 diff
(98.3 %id)
AL710895 human skeletal muscle .a 2921 to 3413 1 to 494       494/494
(100 %)
3 diff
(99.4 %id)
BX494393 Liver .a 2988 to 3654 1 to 668       668/668
(100 %)
2 diff
(99.8 %id)
BG030373 breast, mammary adenocarcinoma, cell line .a 3095 to 3741 1 to 655       655/869
(75 %)
57 diff
(93.5 %id)
BE063854 breast .a 3111 to 3262 1 to 153       153/166
(92 %)
10 diff
(94.0 %id)
BE089588 breast .a 3163 to 3531 372 to 3   tiling clone, Submitted on the opposite strand 370/373
(99 %)
0 diff
(100 %id)
DA641247 Liver .a 3189 to 3721 2 to 538   capped   537/538
(99 %)
4 diff
(99.3 %id)
EC506576 Prostate .a 3222 to 3329 1 to 106       106/106
(100 %)
5 diff
(95.3 %id)
BQ420710 melanotic melanoma, skin .a 3262 to 4130 1 to 872       872/873
(99 %)
8 diff
(99.1 %id)
CN415375 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3291 to 4033 7 to 749       743/749
(99 %)
6 diff
(99.2 %id)
CX783529 human embryonic stem cells .a 3431 to 4204 1 to 774   tiling clone,   774/774
(100 %)
1 diff
(99.9 %id)
BE539257 cervix .a 3439 to 4131 1 to 689       689/803
(85 %)
22 diff
(97.3 %id)
CN415374 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3445 to 3953 1 to 508       508/508
(100 %)
6 diff
(98.9 %id)
BU187564 eye, retinoblastoma .a 3462 to 4326 11 to 874   tiling clone,   864/874
(98 %)
6 diff
(99.4 %id)
DB321331 Liver .a 4648 to 5198 553 to 1   tiling clone,   553/553
(100 %)
2 diff
(99.7 %id)
AK309810 brain .b 1 to 2741 2 to 2742 F28L D408Y L559P E888G tiling clone,   2742/2742
(100 %)
8 diff
(99.8 %id)
AB046850   .c 1 to 4036 1 to 4037 F20L Y272D I607M tiling clone, available from KIAA, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 4037/4038
(99 %)
13 diff
(99.7 %id)
BM193121 leukopheresis .c 3 to 578 1 to 576       576/576
(100 %)
7 diff
(98.8 %id)
BP351768   .c 5 to 632 1 to 628       628/628
(100 %)
13 diff
(98.0 %id)
BP356351   .c 8 to 588 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
BP201457 amygdala .c 9 to 590 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP314268 mammary gland .c 9 to 552 1 to 547       547/583
(93 %)
20 diff
(96.6 %id)
CN360004 embryonic stem cells, cell lines H1, H7, andH9 .c 12 to 704 1 to 693       693/693
(100 %)
3 diff
(99.6 %id)
BP229348 brain .c 12 to 622 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
BP315020 mammary gland .c 12 to 592 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BP315252 mammary gland .c 12 to 593 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
BP356642 mammary gland .c 12 to 592 1 to 582       582/582
(100 %)
19 diff
(96.8 %id)
BP358700 mammary gland .c 12 to 593 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA793833 brain .c 13 to 564 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
CN360003 embryonic stem cells, DMSO-treated H9 cellline .c 23 to 670 1 to 648       648/648
(100 %)
4 diff
(99.4 %id)
CN359999 embryonic stem cells, cell lines H1, H7, andH9 .c 28 to 727 1 to 700       700/700
(100 %)
3 diff
(99.6 %id)
TI_1948150135   .c 31 to 1031 131 to 1145       1015/1462
(69 %)
15 diff
(99.0 %id)
TI_1948150136   .c 31 to 1179 121 to 1252       1132/1409
(80 %)
84 diff
(94.1 %id)
TI_1948150439   .c 31 to 1024 132 to 1127       996/1406
(70 %)
30 diff
(97.9 %id)
TI_1948150440   .c 31 to 1038 118 to 1114       997/1368
(72 %)
36 diff
(97.4 %id)
ES311055 scalp interfollicular dermis, skin .c 32 to 557 1 to 529       529/531
(99 %)
7 diff
(98.7 %id)
CV027046 mixed .c 37 to 230 1 to 194       194/194
(100 %)
1 diff
(99.5 %id)
EL733195 mixed .c 37 to 674 1 to 635       635/641
(99 %)
5 diff
(99.3 %id)
AL556938 placenta .c 45 to 1070 1 to 1022       1022/1022
(100 %)
8 diff
(99.3 %id)
BM810358 astrocytoma grade IV, cell line, brain .c 62 to 753 1 to 696       696/1112
(62 %)
23 diff
(98.0 %id)
CN360002 embryonic stem cells, cell lines H1, H7, andH9 .c 63 to 707 1 to 645       645/645
(100 %)
1 diff
(99.9 %id)
BG767508 melanotic melanoma, high MDR (cell line), skin .c 116 to 720 1 to 608       608/608
(100 %)
8 diff
(98.7 %id)
CV801383 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 128 to 870 1 to 730       730/823
(88 %)
14 diff
(98.3 %id)
AA338652 brain .c 146 to 426 1 to 281       281/281
(100 %)
3 diff
(99.0 %id)
CD651998 Embryonic Stem cells .c 238 to 1007 12 to 774       763/799
(95 %)
20 diff
(97.5 %id)
BM738126 Ascites, stomach .c 239 to 609 1 to 371       371/371
(100 %)
3 diff
(99.2 %id)
EH348516   .c 356 to 425 1 to 71       71/71
(100 %)
4 diff
(94.4 %id)
BF306067 muscle, rhabdomyosarcoma .c 364 to 1177 1 to 807       807/825
(97 %)
40 diff
(95.2 %id)
BG828342 muscle, rhabdomyosarcoma .c 364 to 963 1 to 610       610/978
(62 %)
29 diff
(97.1 %id)
BE387452 melanotic melanoma, skin .c 430 to 1155 39 to 761       723/797
(90 %)
27 diff
(96.7 %id)
CD642682 Embryonic Stem cells .c 432 to 1190 12 to 769       758/771
(98 %)
17 diff
(97.8 %id)
BE384748 melanotic melanoma, skin .c 452 to 1127 6 to 678       671/737
(91 %)
12 diff
(98.4 %id)
BI258962 cervical carcinoma cell line, cervix .c 472 to 1314 1 to 849       845/850
(99 %)
28 diff
(96.8 %id)
CN359998 embryonic stem cells, DMSO-treated H9 cellline .c 541 to 1129 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BQ338554 nervous_normal .c 636 to 850 1 to 219       219/234
(93 %)
22 diff
(90.6 %id)
BQ338548 nervous_normal .c 640 to 851 24 to 238       215/238
(90 %)
18 diff
(92.5 %id)
CV325921 marrow .c 666 to 1076 8 to 417       410/417
(98 %)
9 diff
(97.9 %id)
BM019974 astrocytoma grade IV, cell line, brain .c 725 to 1365 1 to 642       642/642
(100 %)
6 diff
(99.1 %id)
BM810015 astrocytoma grade IV, cell line, brain .c 726 to 1709 26 to 1023   tiling clone,   998/1175
(84 %)
24 diff
(98.0 %id)
TI_59390750   .c 726 to 1365 102 to 742       641/641
(100 %)
5 diff
(99.3 %id)
BX390840   .c 869 to 1667 1 to 802       802/919
(87 %)
36 diff
(96.1 %id)
BE535198 cervix .c 984 to 1655 1 to 673       673/1039
(64 %)
6 diff
(99.5 %id)
BQ422166 embryonal carcinoma, cell line, testis .c 987 to 1853 1 to 868       868/875
(99 %)
5 diff
(99.5 %id)
BG252420 adenocarcinoma, cell line, Liver .c 1003 to 1705 1 to 699       699/890
(78 %)
21 diff
(97.7 %id)
BG251290 adenocarcinoma, cell line, Liver .c 1003 to 1703 1 to 694       696/957
(72 %)
17 diff
(98.3 %id)
BM044200 carcinoma, cell line, Prostate .c 1157 to 1934 1 to 781       781/849
(91 %)
17 diff
(98.0 %id)
BM044486 carcinoma, cell line, Prostate .c 1157 to 1922 1 to 766       766/766
(100 %)
6 diff
(99.3 %id)
BM049659 carcinoma, cell line, Prostate .c 1158 to 2013 1 to 869       867/870
(99 %)
42 diff
(95.2 %id)
BU541798 carcinoma, cell line, Prostate .c 1159 to 1934 1 to 788       788/1000
(78 %)
21 diff
(97.9 %id)
BQ311407 breast_normal .c 1187 to 1445 12 to 271       260/271
(95 %)
12 diff
(95.6 %id)
CN360001 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1281 to 1894 1 to 614       614/618
(99 %)
1 diff
(99.9 %id)
CF121862 lymph .c 1282 to 1664 8 to 391       384/396
(96 %)
27 diff
(93.2 %id)
BQ379447 uterus_tumor .c 1299 to 1724 1 to 426       426/426
(100 %)
6 diff
(98.6 %id)
BX355086.
matches multiple genes
Neuroblastoma Cot 25-normalized .c 1321 to 2345 1 to 1021     also hits gene TTC9B 1021/1032
(98 %)
11 diff
(99.0 %id)
AW499644 lymph .c 1329 to 1628 1 to 300       300/300
(100 %)
30 diff
(90.0 %id)
AW499689 lymph .c 1329 to 1848 1 to 520       520/520
(100 %)
3 diff
(99.5 %id)
TI_158439475   .c 1334 to 2044 78 to 787       710/711
(99 %)
13 diff
(98.2 %id)
BG335649 choriocarcinoma, placenta .c 1338 to 1979 1 to 644       645/952
(67 %)
16 diff
(98.4 %id)
BE734321 choriocarcinoma, placenta .c 1355 to 2192 1 to 838   tiling clone,   838/959
(87 %)
27 diff
(97.2 %id)
CD629461   .c 1358 to 2018 18 to 678       661/678
(97 %)
16 diff
(97.7 %id)
BE900145 choriocarcinoma, placenta .c 1431 to 2022 1 to 590       590/590
(100 %)
5 diff
(99.2 %id)
CK001014 mixed .c 1456 to 2189 1 to 730       730/795
(91 %)
13 diff
(98.4 %id)
DA440878 tongue, tumor tissue .c 1487 to 1837 206 to 556   capped   351/555
(63 %)
7 diff
(98.8 %id)
BG393210 embryonal carcinoma, cell line, testis .c 1510 to 2190 1 to 690   tiling clone,   690/853
(80 %)
30 diff
(96.5 %id)
CB117954 brain .c 1513 to 1868 1 to 356       356/356
(100 %)
2 diff
(99.5 %id)
BG388683 embryonal carcinoma, cell line, testis .c 1545 to 2112 1 to 567       567/642
(88 %)
5 diff
(99.3 %id)
CR735648 carcinoma, cell line, Prostate .c 1572 to 2084 29 to 541       513/549
(93 %)
10 diff
(98.2 %id)
BQ276485 carcinoma, cell line, Prostate .c 1582 to 2516 1 to 949       949/1065
(89 %)
26 diff
(97.6 %id)
BF307794 muscle, rhabdomyosarcoma .c 1601 to 2353 1 to 741       741/941
(78 %)
26 diff
(97.3 %id)
BU430365 lymph .c 1671 to 2079 1 to 409       409/409
(100 %)
6 diff
(98.6 %id)
TI_154151697   .c 1677 to 2125 80 to 528       449/449
(100 %)
4 diff
(99.2 %id)
BU855972 ovary, teratocarcinoma, cell line .c 1709 to 2633 1 to 927       927/929
(99 %)
24 diff
(97.5 %id)
DR760428 embryonic stem .c 1712 to 2489 25 to 802       778/802
(97 %)
9 diff
(98.9 %id)
BU538091 adenocarcinoma, cell line, breast .c 1820 to 2608 1 to 794       794/959
(82 %)
18 diff
(98.2 %id)
CN360000 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1857 to 2528 1 to 671       671/671
(100 %)
10 diff
(98.6 %id)
BQ325012 colon_ins .c 1916 to 2216 300 to 1       300/300
(100 %)
8 diff
(97.4 %id)
R72130 breast .c 2033 to 2369 1 to 336       336/336
(100 %)
3 diff
(99.2 %id)
NM_018144.3   .d 1 to 2528 1 to 2528 exact RefSeq,   2528/2528
(100 %)
0 diff
(100 %id)
AL521445 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 42 to 1005 1 to 957   tiling clone,   957/966
(99 %)
15 diff
(98.5 %id)
AK292295 testis .d 51 to 1913 1 to 1863   tiling clone,   1863/1863
(100 %)
2 diff
(99.9 %id)
AF346603   .d 59 to 1951 1 to 1893       1893/1893
(100 %)
7 diff
(99.7 %id)
AL521444 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1534 to 2472 959 to 26   tiling clone,   934/970
(96 %)
0 diff
(100 %id)
NM_001142627.1   .e 1 to 2091 1 to 2091 exact RefSeq, AAA   2091/2091
(100 %)
0 diff
(100 %id)
AK022640   .e 69 to 2091 4 to 2026   tiling clone, available from FLJ,   2023/2023
(100 %)
5 diff
(99.8 %id)
NM_001142628.1   .f 1 to 2462 1 to 2462 exact RefSeq,   2462/2462
(100 %)
0 diff
(100 %id)
AK301841 testis .f 48 to 1645 1 to 1598 G348E tiling clone,   1598/1598
(100 %)
2 diff
(99.9 %id)
DB027491 testis .f 49 to 585 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
AK022027 whole embryo, mainly body .f 552 to 1885 1 to 1334   available from FLJ,   1334/1334
(100 %)
1 diff
(100.0 %id)
AU120635 whole embryo, mainly body .f 553 to 1459 2 to 899   capped   898/901
(99 %)
18 diff
(98.1 %id)
AK001440   .f 700 to 1885 1 to 1186   tiling clone, available from FLJ,   1186/1186
(100 %)
0 diff
(100 %id)
AW955044   .f 787 to 1443 1 to 659       659/659
(100 %)
11 diff
(98.4 %id)
AL522573 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 851 to 1866 1010 to 1       1010/1012
(99 %)
36 diff
(96.5 %id)
AV728039 hypothalamus .f 967 to 1452 165 to 650       486/652
(74 %)
23 diff
(96.5 %id)
BQ339260 nervous_normal .f 1066 to 1371 320 to 17       304/344
(88 %)
5 diff
(98.6 %id)
BQ337654 nervous_normal .f 1202 to 1581 393 to 11       383/393
(97 %)
0 diff
(100 %id)
CR745906   .f 1220 to 1755 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
H08409 whole brain .f 1221 to 1630 1 to 416     Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 416/425
(97 %)
15 diff
(96.5 %id)
BF955909 nervous_normal .f 1266 to 1357 106 to 16       91/106
(85 %)
1 diff
(99.1 %id)
BE048558 Kidney .f 1323 to 1886 567 to 5       563/599
(93 %)
0 diff
(100 %id)
AI016073   .f 1332 to 1884 560 to 10       551/561
(98 %)
0 diff
(100 %id)
AW572241 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1395 to 1884 504 to 17   AAA   488/491
(99 %)
7 diff
(98.6 %id)
BX453008 placenta .f 1397 to 2397 997 to 1   tiling clone,   997/997
(100 %)
11 diff
(98.9 %id)
DR423860 eye, Pterygium .f 1410 to 2223 1 to 814       814/814
(100 %)
2 diff
(99.8 %id)
AW340366 pooled .f 1469 to 1885 432 to 16   AAA   417/417
(100 %)
1 diff
(99.8 %id)
BU902594 leiomyosarcoma, uterus .f 1473 to 1746 123 to 396   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 274/396
(69 %)
6 diff
(98.5 %id)
AI362748 anaplastic oligodendroglioma, brain .f 1481 to 1885 435 to 31   AAA   405/405
(100 %)
9 diff
(97.8 %id)
AW571578 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1490 to 1886 399 to 3       397/399
(99 %)
0 diff
(100 %id)
AI276915 placenta .f 1504 to 1735 237 to 6       232/237
(97 %)
0 diff
(100 %id)
AI141531 heart .f 1580 to 1885 332 to 27   AAA   306/306
(100 %)
0 diff
(100 %id)
AI560764 anaplastic oligodendroglioma, brain .f 1626 to 1885 289 to 30   AAA   260/260
(100 %)
4 diff
(98.5 %id)
N49789 liver and spleen .f 1835 to 2049 8 to 222   fully sequenced,   215/222
(96 %)
2 diff
(99.1 %id)
BX412347 placenta .f 1864 to 2390 538 to 13       526/763
(68 %)
0 diff
(100 %id)
W78825 liver and spleen .f 1864 to 2231 1 to 371       371/371
(100 %)
23 diff
(93.9 %id)
AI694646 carcinoid, lung .f 1887 to 2469 583 to 1       583/590
(98 %)
7 diff
(98.9 %id)
BM930567 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1916 to 2371 1 to 456       456/460
(99 %)
7 diff
(98.5 %id)
BF433631 carcinoid, lung .f 1922 to 2470 552 to 4   tiling clone,   549/552
(99 %)
0 diff
(100 %id)
BF433804 carcinoid, lung .f 1966 to 2470 508 to 4       505/508
(99 %)
0 diff
(100 %id)
AI870003 anaplastic oligodendroglioma, brain .f 1989 to 2463 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
BF445225 carcinoid, lung .f 1994 to 2470 480 to 4       477/480
(99 %)
0 diff
(100 %id)
CA436374 Bone, Subchondral Bone .f 1995 to 2462 487 to 19   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 469/469
(100 %)
1 diff
(99.8 %id)
AI440186 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 2006 to 2418 412 to 1       412/412
(100 %)
5 diff
(98.8 %id)
N50467 multiple sclerosis lesions .f 2010 to 2327 1 to 321       321/392
(81 %)
4 diff
(99.0 %id)
N49686 liver and spleen .f 2019 to 2469 449 to 1   fully sequenced,   449/449
(100 %)
3 diff
(99.4 %id)
AW105043 pooled .f 2023 to 2465 444 to 1       444/444
(100 %)
4 diff
(99.1 %id)
AI040221 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 2026 to 2424 411 to 13   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 399/399
(100 %)
1 diff
(99.8 %id)
AA987206 carcinoid, lung .f 2044 to 2469 426 to 1       426/427
(99 %)
1 diff
(99.8 %id)
FN166551 breast carcinoma .f 2047 to 2095 1 to 50       50/50
(100 %)
1 diff
(98.0 %id)
AW293140   .f 2109 to 2470 379 to 18   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 362/364
(99 %)
0 diff
(100 %id)
AW295825   .f 2119 to 2417 313 to 15   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 299/299
(100 %)
0 diff
(100 %id)
TI_154093637   .f 2119 to 2462 456 to 113   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 344/1252
(27 %)
1 diff
(100.0 %id)
H08410 whole brain .f 2120 to 2462 358 to 14   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 345/348
(99 %)
6 diff
(98.3 %id)
T79031 liver and spleen .f 2139 to 2407 269 to 1       269/278
(96 %)
12 diff
(95.7 %id)
BE719924 head_neck .f 2145 to 2273 9 to 141       133/148
(89 %)
7 diff
(95.3 %id)
BE719926 head_neck .f 2145 to 2398 41 to 294       254/296
(85 %)
4 diff
(98.7 %id)
BE719927 head_neck .f 2145 to 2398 34 to 286       253/288
(87 %)
5 diff
(98.3 %id)
BI870417 adenocarcinoma, cell line, Liver .f 2171 to 2417 1 to 246   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 246/246
(100 %)
1 diff
(99.6 %id)
AI559361 anaplastic oligodendroglioma, brain .f 2185 to 2417 233 to 1       233/233
(100 %)
1 diff
(99.6 %id)
BE783790 eye, retinoblastoma .f 2222 to 2412 14 to 201       188/201
(93 %)
6 diff
(97.1 %id)
BF939539 brain, glioblastoma (pooled) .f 2273 to 2424 153 to 1       153/153
(100 %)
4 diff
(97.4 %id)
DB545441.
matches multiple genes
hippocampus .f 2387 to 2898 512 to 1   tiling clone, also hits gene NUDT5 512/512
(100 %)
0 diff
(100 %id)
BP394886 pancreatic islet .f 2388 to 2897 510 to 1       510/515
(99 %)
0 diff
(100 %id)
AA355299   .f 2390 to 2740 1 to 352       352/353
(99 %)
3 diff
(99.2 %id)
DB549107.
matches multiple genes
hippocampus .f 2390 to 2846 457 to 1     also hits gene NUDT5 457/457
(100 %)
0 diff
(100 %id)
AW958473   .f 2391 to 2919 1 to 532       532/589
(90 %)
10 diff
(98.4 %id)
BE832376 marrow .f 2473 to 2650 1 to 179       179/179
(100 %)
7 diff
(96.1 %id)
FN052737 breast carcinoma .f 2489 to 2553 1 to 66       66/66
(100 %)
1 diff
(98.5 %id)
BE835232 prostate_normal .f 2582 to 3106 1 to 526   tiling clone,   526/534
(98 %)
5 diff
(99.1 %id)
BE835292 prostate_normal .f 2582 to 2984 1 to 404   tiling clone,   404/404
(100 %)
3 diff
(99.3 %id)
BE835294 prostate_normal .f 2582 to 3055 1 to 475   tiling clone,   475/475
(100 %)
4 diff
(99.2 %id)
BE697294 colon .f 2864 to 2965 22 to 123       102/123
(82 %)
9 diff
(92.7 %id)
BP212860 cerebrum .g 1 to 578 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
NR_024576.1   .g 1 to 2232 1 to 2232 exact RefSeq, tiling clone, AAA   2232/2232
(100 %)
0 diff
(100 %id)
TI_44343031   .g 2 to 824 114 to 937       824/955
(86 %)
31 diff
(96.8 %id)
BG705762 brain, hypothalamus .g 4 to 661 1 to 657       657/657
(100 %)
10 diff
(98.5 %id)
BG706840 brain, hypothalamus .g 4 to 877 1 to 876       876/877
(99 %)
20 diff
(97.8 %id)
BG702843 brain, hippocampus .g 4 to 748 1 to 743       743/743
(100 %)
7 diff
(99.1 %id)
BI666838 brain, hypothalamus .g 4 to 824 1 to 822       822/840
(97 %)
25 diff
(97.1 %id)
DN990684 brain, whole brain .g 7 to 560 7 to 560       554/560
(98 %)
1 diff
(99.9 %id)
DB471786.
matches multiple genes
hippocampus .g 13 to 498 1 to 487     also hits gene NUDT5 487/487
(100 %)
1 diff
(99.8 %id)
DB474665.
matches multiple genes
hippocampus .g 13 to 519 1 to 507     also hits gene NUDT5 507/507
(100 %)
10 diff
(98.1 %id)
BI552496 brain, hippocampus .g 23 to 762 1 to 749       749/878
(85 %)
28 diff
(96.9 %id)
DB470574.
matches multiple genes
hippocampus .g 28 to 495 1 to 468     also hits gene NUDT5 468/468
(100 %)
1 diff
(99.8 %id)
TI_44171151   .g 28 to 762 130 to 873       744/1002
(74 %)
32 diff
(96.9 %id)
DA161095 amygdala .g 30 to 596 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA849200 placenta .g 36 to 602 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BP308041 brain .g 37 to 609 1 to 574       572/583
(98 %)
5 diff
(99.2 %id)
DA163733 amygdala .g 38 to 603 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BX493535   .g 38 to 625 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
DB446989 testis .g 38 to 476 1 to 439     Submitted on the opposite strand 439/439
(100 %)
2 diff
(99.6 %id)
TI_57238856   .g 41 to 890 30 to 876       847/876
(96 %)
15 diff
(98.3 %id)
BG772766 testis .g 43 to 715 1 to 672       672/672
(100 %)
13 diff
(98.1 %id)
BI550782 brain, hippocampus .g 44 to 823 1 to 780       780/780
(100 %)
11 diff
(98.6 %id)
BI915587 brain .g 46 to 890 1 to 842       842/842
(100 %)
9 diff
(99.0 %id)
DB265425 uterus .g 46 to 612 2 to 568   capped   567/573
(98 %)
3 diff
(99.5 %id)
DA160774 amygdala .g 49 to 619 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA176186 amygdala .g 49 to 624 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA262738 caudate nucleus .g 49 to 609 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA266763 caudate nucleus .g 49 to 598 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA295791 hippocampus .g 49 to 609 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA714350   .g 49 to 602 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA716946   .g 49 to 592 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB036410 testis .g 49 to 623 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB213275 trachea .g 49 to 601 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DB248739 uterus .g 49 to 570 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
BG723109 testis .g 50 to 781 1 to 733       733/733
(100 %)
8 diff
(99.0 %id)
BC026179 testis .g 51 to 2232 1 to 2182 exact available from MGC, AAA   2182/2182
(100 %)
7 diff
(99.7 %id)
BP208465 cerebellum .g 51 to 623 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DB032673 testis .g 52 to 603 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BI823354 pooled brain, lung, testis .g 55 to 892 1 to 851       851/880
(96 %)
20 diff
(97.8 %id)
TI_57202869   .g 55 to 892 30 to 880       851/909
(93 %)
22 diff
(97.6 %id)
DA354610 substantia nigra .g 57 to 607 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA156602 amygdala .g 67 to 609 2 to 545   capped   544/554
(98 %)
3 diff
(99.5 %id)
AU125111   .g 67 to 925 2 to 861   capped   860/867
(99 %)
15 diff
(98.3 %id)
DA174624 amygdala .g 70 to 587 2 to 520   capped   519/519
(100 %)
2 diff
(99.7 %id)
DA306281 hippocampus .g 70 to 625 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA366306 subthalamic nucleus .g 70 to 609 2 to 541   capped   540/543
(99 %)
2 diff
(99.7 %id)
DA745779   .g 70 to 635 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
BG699515 brain, hippocampus .g 74 to 892 5 to 831       827/843
(98 %)
23 diff
(97.3 %id)
DA265436 caudate nucleus .g 80 to 635 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB473180.
matches multiple genes
hippocampus .g 86 to 552 1 to 467     also hits gene NUDT5 467/467
(100 %)
0 diff
(100 %id)
BE260568 brain, neuroblastoma .g 98 to 758 1 to 652       654/989
(66 %)
31 diff
(96.9 %id)
DR432532 mixed .g 147 to 831 5 to 686   fully sequenced,   682/686
(99 %)
5 diff
(99.3 %id)
DR433112 mixed .g 147 to 794 5 to 652   fully sequenced,   648/652
(99 %)
1 diff
(99.9 %id)
DR433172 mixed .g 147 to 828 5 to 686   fully sequenced,   682/686
(99 %)
4 diff
(99.5 %id)
DR432947 mixed .g 147 to 858 5 to 713   fully sequenced,   709/713
(99 %)
1 diff
(99.9 %id)
DR432952 mixed .g 147 to 858 5 to 712   fully sequenced,   708/712
(99 %)
1 diff
(99.9 %id)
TI_1948093719   .g 147 to 925 125 to 906       782/1311
(59 %)
13 diff
(99.1 %id)
CV024398 mixed .g 148 to 750 1 to 603       603/603
(100 %)
2 diff
(99.7 %id)
TI_1948093886   .g 148 to 880 126 to 864       739/1316
(56 %)
20 diff
(98.5 %id)
DR433086 mixed .g 155 to 795 13 to 645   fully sequenced,   633/645
(98 %)
15 diff
(97.7 %id)
TI_1948093562   .g 155 to 767 147 to 763       617/1408
(43 %)
18 diff
(98.8 %id)
TI_1948094054   .g 155 to 880 134 to 869       736/1428
(51 %)
20 diff
(98.6 %id)
BI758500 brain .g 161 to 728 130 to 689       560/689
(81 %)
17 diff
(97.6 %id)
TI_57217286   .g 161 to 728 130 to 689       560/689
(81 %)
17 diff
(97.6 %id)
DA270036 caudate nucleus .g 185 to 752 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA167761 amygdala .g 268 to 817 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BG910449 anaplastic oligodendroglioma with 1p/19qloss, brain .g 287 to 1097 1 to 804       804/809
(99 %)
16 diff
(98.1 %id)
DR433109 mixed .g 738 to 1391 671 to 18   fully sequenced,   654/671
(97 %)
0 diff
(100 %id)
DR433085 mixed .g 762 to 1391 646 to 18   fully sequenced,   629/646
(97 %)
1 diff
(99.9 %id)
DR433167 mixed .g 798 to 1391 604 to 18   fully sequenced,   587/604
(97 %)
5 diff
(99.2 %id)
DR432533 mixed .g 801 to 1391 597 to 18   fully sequenced,   580/597
(97 %)
5 diff
(99.2 %id)
DR432948 mixed .g 828 to 1391 581 to 18   fully sequenced,   564/581
(97 %)
0 diff
(100 %id)
DR432953 mixed .g 828 to 1391 581 to 18   fully sequenced,   564/581
(97 %)
0 diff
(100 %id)
AU148842   .g 1669 to 2232 563 to 1       563/566
(99 %)
9 diff
(98.5 %id)
AI654953 pooled germ cell tumors .g 1794 to 2232 439 to 1       439/439
(100 %)
2 diff
(99.6 %id)
AA876478 epithelium (cell line), Prostate .g 1817 to 2204 389 to 1       389/389
(100 %)
3 diff
(99.3 %id)
AW592844 pooled .g 1822 to 2230 414 to 5       410/414
(99 %)
0 diff
(100 %id)
AA815300   .g 1829 to 2236 407 to 1       407/407
(100 %)
2 diff
(99.6 %id)
AA927169 pooled .g 1896 to 2233 339 to 3       337/339
(99 %)
0 diff
(100 %id)
AA961270 pooled .g 1914 to 2229 316 to 1       316/316
(100 %)
3 diff
(99.1 %id)
DB512142 testis .g 1937 to 2234 104 to 401     Submitted on the opposite strand 298/401
(74 %)
6 diff
(98.6 %id)
AA644274 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 2053 to 2234 182 to 1       182/182
(100 %)
0 diff
(100 %id)
BX477824   .h-u 1 to 648 1 to 648   tiling clone,   648/648
(100 %)
1 diff
(99.9 %id)
DA320505 hippocampus .h-u 176 to 700 2 to 526   to resequence, capped   525/528
(99 %)
4 diff
(99.3 %id)
BG678703 skin, squamous cell carcinoma .h-u 179 to 1002 1 to 826   tiling clone,   826/827
(99 %)
12 diff
(98.6 %id)
H62097 ovarian tumor, ovary .h-u 366 to 804 1 to 443       443/443
(100 %)
10 diff
(97.8 %id)
CK005779 brain/CNS, Human Brain - Frontal Cortex .h-u 685 to 1364 1 to 682   tiling clone,   682/682
(100 %)
12 diff
(98.3 %id)
H61192 ovarian tumor, ovary .h-u 1119 to 1467 356 to 1   tiling clone,   356/367
(97 %)
7 diff
(98.1 %id)
DB309073 hippocampus .h-u 2184 to 2740 559 to 1   tiling clone, to resequence,   559/559
(100 %)
7 diff
(98.8 %id)
AW369112 head_neck .h-u 2626 to 3213 1 to 584   tiling clone,   584/586
(99 %)
6 diff
(99.0 %id)
W23767 lung .h-u 2744 to 3099 16 to 374   tiling clone,   359/376
(95 %)
6 diff
(98.5 %id)
AI221427 pooled .h-u 2990 to 3294 1 to 305   tiling clone, Submitted on the opposite strand 305/305
(100 %)
0 diff
(100 %id)
FN106976 breast carcinoma .h-u 3020 to 3113 1 to 91       91/92
(98 %)
4 diff
(95.7 %id)
DB522353 testis .h-u 3379 to 3838 1 to 460   tiling clone, Submitted on the opposite strand 460/460
(100 %)
3 diff
(99.4 %id)
AI792767 Kidney .h-u 3542 to 3973 1 to 432       432/432
(100 %)
5 diff
(98.9 %id)
AI792769 Kidney .h-u 3542 to 3973 1 to 432       432/432
(100 %)
2 diff
(99.6 %id)
AW020478 cochlea, ear .h-u 3542 to 3979 1 to 438   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 438/438
(100 %)
7 diff
(98.5 %id)
AW020636 cochlea, ear .h-u 3542 to 3979 1 to 438   tiling clone, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 438/438
(100 %)
5 diff
(98.9 %id)
AI733123 Kidney .h-u 3575 to 3964 399 to 10       390/399
(97 %)
0 diff
(100 %id)
AI733125 Kidney .h-u 3575 to 3973 399 to 1       399/399
(100 %)
2 diff
(99.5 %id)
AA918663 Kidney .h-u 3625 to 3975 351 to 1       351/351
(100 %)
0 diff
(100 %id)
AA916221 Kidney .h-u 3670 to 3973 304 to 1       304/304
(100 %)
0 diff
(100 %id)
N91876 lung .h-u 3709 to 3980 272 to 1   tiling clone,   272/272
(100 %)
0 diff
(100 %id)
BQ927025 brain, neuroblastoma, cell line .i 1 to 889 1 to 892   tiling clone,   892/939
(94 %)
15 diff
(98.5 %id)
BM019022 astrocytoma grade IV, cell line, brain .i 521 to 1063 16 to 551   tiling clone,   536/551
(97 %)
20 diff
(96.4 %id)
TI_59389700   .i 521 to 1063 139 to 674       536/549
(97 %)
20 diff
(96.4 %id)
CV325925 marrow .i 700 to 1110 425 to 15     Submitted on the opposite strand 411/425
(96 %)
2 diff
(99.6 %id)
BQ304721 breast .i 723 to 1204 26 to 504   tiling clone,   479/504
(95 %)
15 diff
(97.1 %id)
BQ304724 breast .i 723 to 1204 26 to 504       479/504
(95 %)
15 diff
(97.1 %id)
BQ303333 breast .i 729 to 1170 1 to 442   tiling clone,   442/442
(100 %)
1 diff
(99.8 %id)
CV325916 marrow .i 733 to 1074 348 to 7     Submitted on the opposite strand 342/348
(98 %)
2 diff
(99.5 %id)
NR_024577.1   .j 1 to 2365 1 to 2365 exact RefSeq, tiling clone, AAA   2365/2365
(100 %)
0 diff
(100 %id)
DB454249.
matches multiple genes
testis .j 28 to 500 1 to 473     also hits gene NUDT5 473/473
(100 %)
1 diff
(99.8 %id)
DB457301.
matches multiple genes
testis .j 37 to 502 1 to 466     also hits gene NUDT5 466/466
(100 %)
2 diff
(99.6 %id)
BP251468 hippocampus .j 48 to 634 1 to 587       587/588
(99 %)
3 diff
(99.5 %id)
AK057532 testis .j 60 to 2364 1 to 2305 exact available from FLJ,   2305/2305
(100 %)
5 diff
(99.8 %id)
DB026597 testis .j 61 to 619 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DB064687 testis .j 63 to 602 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA612636   .j 89 to 653 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
CX762659 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 155 to 984 85 to 779     Submitted on the opposite strand 566/797
(71 %)
45 diff
(94.4 %id)
BF982114 duodenal adenocarcinoma, cell line, small intestine .j 485 to 1258 1 to 777       777/891
(87 %)
33 diff
(96.3 %id)
BP332058 renal proximal tubule .j 509 to 1092 1 to 585       585/586
(99 %)
5 diff
(99.2 %id)
BM803243 ovary (pool of 3) .j 598 to 1397 1 to 804       804/1074
(74 %)
10 diff
(99.1 %id)
DA135099 alzheimer cortex .j 605 to 1139 2 to 537   capped   536/536
(100 %)
4 diff
(99.3 %id)
BY798394 eye .j 608 to 1199 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
CF135057 CNCAP(3)T-225 cell line, Prostate .j 771 to 1156 1 to 386       386/386
(100 %)
5 diff
(98.8 %id)
BG876488 denis_drash .j 772 to 1254 6 to 488       483/488
(98 %)
7 diff
(98.6 %id)
TI_154163247   .j 778 to 1480 81 to 776       696/696
(100 %)
30 diff
(95.7 %id)
AA322680 brain, cerebellum .j 999 to 1245 1 to 247       247/247
(100 %)
0 diff
(100 %id)
R90889 brain .j 1063 to 1478 1 to 420       420/447
(93 %)
7 diff
(98.5 %id)
AW883354 ovary .j 1257 to 1477 225 to 3       223/240
(92 %)
3 diff
(98.8 %id)
FN115381 breast carcinoma .j 1523 to 1584 1 to 62       62/66
(93 %)
1 diff
(98.5 %id)
DB336623 testis .j 1782 to 2364 583 to 1       583/583
(100 %)
2 diff
(99.7 %id)
BI870429 adenocarcinoma, cell line, Liver .k 1 to 716 1 to 718 I44M F172L V173* tiling clone,   718/727
(98 %)
11 diff
(98.5 %id)
TI_57230907   .k 1 to 716 48 to 765 I44M F172L V173*     718/727
(98 %)
11 diff
(98.5 %id)
BU860216 adenocarcinoma, cell line, breast .l 1 to 768 1 to 785   tiling clone,   785/937
(83 %)
28 diff
(97.1 %id)
BI859618 breast, mammary adenocarcinoma, cell line .l 464 to 1250 1 to 797   tiling clone,   797/809
(98 %)
15 diff
(98.2 %id)
TI_57190661   .l 464 to 1250 86 to 882       797/809
(98 %)
15 diff
(98.2 %id)
BG771883 testis .m 1 to 674 1 to 672 G33D C94V Q95R I96S P97H ... tiling clone,   672/672
(100 %)
11 diff
(98.4 %id)
BG772838 testis .m 1 to 702 1 to 702 G33D tiling clone,   702/702
(100 %)
3 diff
(99.6 %id)
N91406 liver and spleen .n 1 to 404 1 to 405   tiling clone,   405/405
(100 %)
7 diff
(98.3 %id)
BG533437 Liver .n 413 to 1045 1 to 632   tiling clone,   632/632
(100 %)
3 diff
(99.6 %id)
N69378 liver and spleen .n 1584 to 1997 417 to 1   tiling clone,   417/418
(99 %)
9 diff
(97.9 %id)
AL522574 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .o 1 to 959 8 to 965 exact tiling clone,   965/965
(100 %)
17 diff
(98.3 %id)
BM544207 ovary (pool of 3) .o 1 to 705 6 to 713 exact     708/1137
(62 %)
21 diff
(98.2 %id)
BM919118 pooled pancreas and spleen .o 5 to 918 1 to 922 exact     922/1057
(87 %)
24 diff
(97.8 %id)
DA277497 corpus callosum .o 14 to 566 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
CV316044 nervous_tumor .o 315 to 698 397 to 16     Submitted on the opposite strand 382/397
(96 %)
0 diff
(100 %id)
CV316048 nervous_tumor .o 315 to 698 397 to 16     Submitted on the opposite strand 382/397
(96 %)
0 diff
(100 %id)
CR607709 placenta .o 551 to 2260 1 to 1710   tiling clone,   1710/1710
(100 %)
0 diff
(100 %id)
BX453009 placenta .o 551 to 1478 1 to 928       928/928
(100 %)
4 diff
(99.6 %id)
BQ712435 Spleen .p 1 to 791 1 to 797 exact tiling clone,   797/914
(87 %)
13 diff
(98.6 %id)
DN919188   .q 1 to 530 16 to 545       530/546
(97 %)
8 diff
(98.6 %id)
DN920549   .q 1 to 221 1 to 221   tiling clone,   221/221
(100 %)
1 diff
(99.6 %id)
DN920550   .q 142 to 530 390 to 2   tiling clone,   389/390
(99 %)
0 diff
(100 %id)
CN426433 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .q 473 to 953 1 to 480   tiling clone,   480/480
(100 %)
3 diff
(99.4 %id)
DA185676 amygdala .q 928 to 1484 2 to 558   tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
CK431030 eye, lacrimal gland .q 1238 to 1864 1 to 627   tiling clone,   627/627
(100 %)
0 diff
(100 %id)
BQ343348 nervous_tumor .q 1818 to 2244 431 to 5   tiling clone,   427/431
(99 %)
0 diff
(100 %id)
BU617299 Bone, Subchondral Bone .q 1986 to 2696 729 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 711/711
(100 %)
7 diff
(99.1 %id)
DA842645 placenta .r 1 to 560 2 to 562   tiling clone, capped   561/561
(100 %)
4 diff
(99.3 %id)
CB145222 Liver .r 70 to 420 1 to 351       351/351
(100 %)
1 diff
(99.8 %id)
CN415376 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .r 142 to 684 1 to 543   tiling clone,   543/543
(100 %)
1 diff
(99.9 %id)
BE541430 cervix .r 164 to 746 1 to 592   tiling clone,   592/592
(100 %)
24 diff
(96.0 %id)
BF892774 marrow .r 203 to 680 492 to 17     Submitted on the opposite strand 476/492
(96 %)
0 diff
(100 %id)
BG013928 placenta_normal .r 233 to 729 497 to 1       497/497
(100 %)
1 diff
(99.8 %id)
AW772128 Kidney .r 240 to 614 379 to 5       375/379
(98 %)
0 diff
(100 %id)
BF894765 marrow .r 261 to 683 445 to 25     Submitted on the opposite strand 421/445
(94 %)
0 diff
(100 %id)
BF890995 marrow .r 339 to 534 207 to 12     Submitted on the opposite strand 196/207
(94 %)
0 diff
(100 %id)
BF891405 marrow .r 339 to 559 229 to 8     Submitted on the opposite strand 222/229
(96 %)
0 diff
(100 %id)
BE327123 carcinoid, lung .r 339 to 766 427 to 1       427/427
(100 %)
0 diff
(100 %id)
BF892588 marrow .r 453 to 617 1 to 165       165/165
(100 %)
6 diff
(96.4 %id)
DT216891 brain .r 459 to 1158 1 to 699   tiling clone,   699/699
(100 %)
3 diff
(99.6 %id)
BQ309710 breast .r 488 to 817 1 to 330       330/330
(100 %)
20 diff
(94.0 %id)
AW856638 colon .r 492 to 936 1 to 440       440/451
(97 %)
17 diff
(96.3 %id)
BQ309861 breast .r 493 to 817 1 to 324       324/324
(100 %)
7 diff
(97.9 %id)
AW811678 stomach .r 494 to 680 208 to 23       186/208
(89 %)
0 diff
(100 %id)
BE153569 head_neck .r 494 to 817 12 to 332       321/332
(96 %)
6 diff
(98.2 %id)
BE155253 head_neck .r 494 to 817 16 to 339       324/339
(95 %)
6 diff
(98.3 %id)
BE155417 head_neck .r 494 to 817 14 to 336       323/336
(96 %)
6 diff
(98.3 %id)
BE064814 breast .r 495 to 817 1 to 322       322/322
(100 %)
6 diff
(98.2 %id)
BE065071 breast .r 495 to 936 1 to 444       444/447
(99 %)
30 diff
(93.3 %id)
CV407278 breast .r 495 to 936 24 to 468       445/477
(93 %)
33 diff
(93.1 %id)
BM016319 breast, mammary adenocarcinoma, cell line .r 495 to 1100 10 to 613   AAA   604/614
(98 %)
8 diff
(98.7 %id)
TI_59394730   .r 495 to 1100 97 to 700   AAA   604/614
(98 %)
8 diff
(98.7 %id)
BE064661 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/327
(97 %)
1 diff
(99.7 %id)
BE064669 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/573
(55 %)
2 diff
(99.7 %id)
BE064852 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/328
(97 %)
0 diff
(100 %id)
BE064859 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/328
(97 %)
0 diff
(100 %id)
BE064933 breast .r 498 to 817 321 to 1     Submitted on the opposite strand 321/472
(68 %)
4 diff
(99.2 %id)
BE064935 breast .r 498 to 817 321 to 1     Submitted on the opposite strand 321/466
(68 %)
6 diff
(98.8 %id)
BE064936 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/595
(53 %)
1 diff
(99.9 %id)
BE064938 breast .r 498 to 817 321 to 1     Submitted on the opposite strand 321/522
(61 %)
4 diff
(99.3 %id)
BE064940 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/551
(58 %)
1 diff
(99.9 %id)
BE064945 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/573
(55 %)
2 diff
(99.7 %id)
BE064968 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/397
(80 %)
8 diff
(98.0 %id)
BE064971 breast .r 498 to 817 321 to 1     Submitted on the opposite strand 321/329
(97 %)
5 diff
(98.5 %id)
BE064972 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/328
(97 %)
1 diff
(99.7 %id)
BE065050 breast .r 498 to 817 320 to 1     Submitted on the opposite strand 320/327
(97 %)
4 diff
(98.8 %id)
BE153963 head_neck .r 498 to 817 28 to 353       326/353
(92 %)
6 diff
(98.4 %id)
BE154081 head_neck .r 498 to 817 320 to 1     Submitted on the opposite strand 320/325
(98 %)
0 diff
(100 %id)
BE155089 head_neck .r 498 to 817 320 to 1     Submitted on the opposite strand 320/326
(98 %)
4 diff
(98.8 %id)
BE155261 head_neck .r 498 to 817 23 to 342       320/342
(93 %)
6 diff
(98.3 %id)
BE155488 head_neck .r 498 to 817 323 to 1     Submitted on the opposite strand 323/326
(99 %)
5 diff
(98.5 %id)
BQ309894 breast .r 498 to 817 321 to 1       321/329
(97 %)
4 diff
(98.8 %id)
BQ321128 colon .r 498 to 817 17 to 340       324/340
(95 %)
6 diff
(98.3 %id)
BQ356418 head_neck .r 498 to 817 320 to 1       320/327
(97 %)
9 diff
(97.3 %id)
BQ356721 head_neck .r 498 to 817 11 to 330       320/330
(96 %)
6 diff
(98.2 %id)
BQ357585 head_neck .r 498 to 817 10 to 329       320/329
(97 %)
2 diff
(99.4 %id)
BE065056 breast .r 500 to 817 8 to 327       320/327
(97 %)
6 diff
(98.2 %id)
BE153530 head_neck .r 500 to 817 1 to 318       318/318
(100 %)
10 diff
(96.9 %id)
BE153670 head_neck .r 500 to 888 14 to 401       388/401
(96 %)
6 diff
(98.6 %id)
BE155180 head_neck .r 500 to 817 13 to 330       318/330
(96 %)
6 diff
(98.2 %id)
BQ357588 head_neck .r 500 to 903 10 to 411       402/411
(97 %)
6 diff
(98.6 %id)
BE153619 head_neck .r 502 to 817 1 to 314       314/314
(100 %)
6 diff
(98.1 %id)
BE064811 breast .r 503 to 817 1 to 312       312/312
(100 %)
3 diff
(99.1 %id)
BE064647 breast .r 508 to 817 21 to 327       307/327
(93 %)
6 diff
(98.2 %id)
BE693337 breast .r 513 to 817 9 to 311       303/311
(97 %)
6 diff
(98.1 %id)
BE155077 head_neck .r 517 to 817 15 to 313       299/313
(95 %)
6 diff
(98.1 %id)
BQ356631 head_neck .r 520 to 817 22 to 319       298/319
(93 %)
6 diff
(98.2 %id)
BE155304 head_neck .r 523 to 796 12 to 284       273/306
(89 %)
15 diff
(95.1 %id)
BE160783 head_neck .r 523 to 796 12 to 284       273/306
(89 %)
15 diff
(95.1 %id)
BE693309 breast .r 525 to 936 7 to 418       412/440
(93 %)
17 diff
(96.2 %id)
BQ309896 breast .r 532 to 817 1 to 284       284/284
(100 %)
16 diff
(94.4 %id)
BQ356688 head_neck .r 541 to 817 281 to 1       281/281
(100 %)
14 diff
(95.1 %id)
CX785594 human embryonic stem cells .r 551 to 1358 1 to 807       807/807
(100 %)
3 diff
(99.7 %id)
TI_154134719   .r 552 to 1098 651 to 107   AAA   545/1021
(53 %)
24 diff
(97.7 %id)
BE155056 head_neck .r 554 to 923 377 to 2     Submitted on the opposite strand 376/379
(99 %)
0 diff
(100 %id)
BG679689 skin, squamous cell carcinoma .r 588 to 1497 1 to 909   tiling clone,   909/917
(99 %)
24 diff
(97.4 %id)
BE938262 testis_normal .r 593 to 817 225 to 1       225/225
(100 %)
11 diff
(95.2 %id)
BE153518 head_neck .r 605 to 734 1 to 130       130/130
(100 %)
5 diff
(96.2 %id)
BE693325 breast .r 635 to 817 1 to 183       183/183
(100 %)
2 diff
(99.0 %id)
BG469693 adenocarcinoma cell line, colon .r 687 to 1115 1 to 430   tiling clone,   430/435
(98 %)
8 diff
(98.2 %id)
BQ309860 breast .r 714 to 817 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
CN263773 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .r 726 to 1096 30 to 400   AAA   371/400
(92 %)
6 diff
(98.5 %id)
BG677246 skin, squamous cell carcinoma .r 921 to 1075 370 to 535       478/551
(86 %)
28 diff
(95.0 %id)
AI825386 pooled germ cell tumors .r 1021 to 1364 5 to 350     Submitted on the opposite strand 346/350
(98 %)
6 diff
(98.3 %id)
BF086603 placenta_normal .r 1052 to 1387 341 to 6       336/348
(96 %)
0 diff
(100 %id)
BF086615 placenta_normal .r 1052 to 1330 349 to 69       281/353
(79 %)
0 diff
(100 %id)
AA393480   .r 1096 to 1567 1 to 469   tiling clone,   469/469
(100 %)
3 diff
(99.4 %id)
R94110 liver and spleen .r 1097 to 1592 1 to 505       505/508
(99 %)
11 diff
(97.9 %id)
T89897 liver and spleen .r 1098 to 1330 1 to 233       233/233
(100 %)
2 diff
(99.2 %id)
AI934407 Kidney .r 1104 to 1665 562 to 1       562/562
(100 %)
0 diff
(100 %id)
AW204203   .r 1106 to 1600 512 to 18   AAA   495/501
(98 %)
4 diff
(99.3 %id)
AA001207 liver and spleen .r 1133 to 1420 1 to 295       295/311
(94 %)
8 diff
(97.5 %id)
BE672538 carcinoid, lung .r 1139 to 1666 530 to 4       527/530
(99 %)
0 diff
(100 %id)
DB328501 placenta .r 1150 to 1668 519 to 1       519/520
(99 %)
0 diff
(100 %id)
AA778306 heart .r 1155 to 1664 513 to 4       510/513
(99 %)
0 diff
(100 %id)
BE502974 carcinoid, lung .r 1176 to 1667 495 to 4       492/495
(99 %)
0 diff
(100 %id)
AI718504 colon .r 1177 to 1666 493 to 4       490/493
(99 %)
0 diff
(100 %id)
AW299732 Kidney .r 1180 to 1663 484 to 1       484/484
(100 %)
5 diff
(99.0 %id)
AA778312 heart .r 1181 to 1664 487 to 3       485/487
(99 %)
0 diff
(100 %id)
AW008224 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .r 1186 to 1668 486 to 4       483/486
(99 %)
0 diff
(100 %id)
BF196507 Kidney .r 1199 to 1664 477 to 12   AAA   466/466
(100 %)
8 diff
(98.3 %id)
AI580299 Kidney .r 1200 to 1601 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI867457 pooled germ cell tumors .r 1202 to 1664 463 to 1       463/463
(100 %)
3 diff
(99.4 %id)
AI640173 Kidney .r 1208 to 1663 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI911561 Kidney .r 1213 to 1669 463 to 7       457/463
(98 %)
0 diff
(100 %id)
AI521962 Kidney .r 1214 to 1668 462 to 8       455/462
(98 %)
0 diff
(100 %id)
AI823832 2 pooled tumors (clear cell type), Kidney .r 1226 to 1672 453 to 7   tiling clone,   447/453
(98 %)
0 diff
(100 %id)
AI288888 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .r 1228 to 1668 442 to 3       440/442
(99 %)
0 diff
(100 %id)
BE467960 carcinoid, lung .r 1233 to 1664 435 to 4       432/435
(99 %)
0 diff
(100 %id)
AI934441 Kidney .r 1234 to 1665 434 to 3       432/434
(99 %)
0 diff
(100 %id)
AA009773 liver and spleen .r 1240 to 1671 441 to 1       441/442
(99 %)
10 diff
(97.8 %id)
AA483527 colon .r 1242 to 1666 432 to 9       424/432
(98 %)
0 diff
(100 %id)
AI802712 colon, colonic mucosa from 5 ulcerative colitispatients .r 1247 to 1672 427 to 2       426/427
(99 %)
0 diff
(100 %id)
AW612103 Kidney .r 1247 to 1668 428 to 7       422/428
(98 %)
0 diff
(100 %id)
AW342106 carcinoid, lung .r 1269 to 1671 403 to 1       403/403
(100 %)
4 diff
(99.1 %id)
AW614404 Kidney .r 1269 to 1606 338 to 1       338/338
(100 %)
0 diff
(100 %id)
AI700874 Kidney .r 1277 to 1671 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
AW469932 2 pooled tumors (clear cell type), Kidney .r 1280 to 1667 391 to 4       388/391
(99 %)
0 diff
(100 %id)
F29737 pectoral muscle (after mastectomy) .r 1286 to 1604 1 to 319       319/319
(100 %)
1 diff
(99.7 %id)
AW083293 colon, moderately differentiated adenocarcinoma .r 1288 to 1675 401 to 14       388/401
(96 %)
0 diff
(100 %id)
AW770207 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .r 1289 to 1668 382 to 2       381/382
(99 %)
0 diff
(100 %id)
AA934834 metastatic prostate bone lesion .r 1291 to 1612 1 to 323       323/323
(100 %)
5 diff
(98.5 %id)
AI583726 pooled germ cell tumors .r 1302 to 1664 363 to 1       363/363
(100 %)
0 diff
(100 %id)
W92713 liver and spleen .r 1309 to 1668 375 to 4       372/375
(99 %)
0 diff
(100 %id)
AW302136 Kidney .r 1309 to 1668 360 to 1       360/360
(100 %)
5 diff
(98.7 %id)
BE327360 carcinoid, lung .r 1323 to 1666 343 to 1       343/343
(100 %)
3 diff
(99.2 %id)
AI262050 Kidney .r 1355 to 1668 315 to 2       314/315
(99 %)
0 diff
(100 %id)
T64641 Liver .r 1357 to 1666 313 to 4       310/313
(99 %)
0 diff
(100 %id)
AA934619 pooled germ cell tumors .r 1362 to 1665 305 to 2       304/305
(99 %)
0 diff
(100 %id)
C02300   .r 1373 to 1664 1 to 292       292/331
(88 %)
5 diff
(98.5 %id)
BF762818 colon_est .r 1379 to 1534 163 to 9     Submitted on the opposite strand 155/163
(95 %)
0 diff
(100 %id)
T93614 liver and spleen .r 1404 to 1665 268 to 5       264/401
(65 %)
0 diff
(100 %id)
CN289320 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .r 1410 to 1993 1 to 585 P38L tiling clone,   585/585
(100 %)
2 diff
(99.7 %id)
BI333272 cervical carcinoma cell line, cervix .r 1423 to 1676 1 to 255   AAA   255/255
(100 %)
3 diff
(98.9 %id)
AA535965 colon .r 1465 to 1600 136 to 1       136/136
(100 %)
1 diff
(99.3 %id)
FN097055 breast carcinoma .r 1500 to 1604 1 to 104       104/107
(97 %)
4 diff
(96.3 %id)
EC581502 Prostate .r 1519 to 1641 115 to 1       115/115
(100 %)
8 diff
(93.1 %id)
EC515553 Prostate .r 1547 to 1666 120 to 3       118/120
(98 %)
0 diff
(100 %id)
AA435699   .r 1568 to 1673 108 to 4       105/108
(97 %)
0 diff
(100 %id)
BE152282 head_neck .r 1590 to 1756 1 to 169       169/169
(100 %)
7 diff
(95.9 %id)
AI084976 liver and spleen .s-u 1 to 415 412 to 1   tiling clone,   412/412
(100 %)
5 diff
(98.8 %id)
BF476115 Kidney .s-u 188 to 602 420 to 6   tiling clone,   415/420
(98 %)
0 diff
(100 %id)
AA078757 Pancreas .s-u 446 to 780 1 to 339 S38G tiling clone, fully sequenced,   339/339
(100 %)
8 diff
(97.7 %id)
AA078758 Pancreas .s-u 750 to 998 254 to 1   tiling clone, fully sequenced,   254/254
(100 %)
7 diff
(97.3 %id)
DB045547 testis .t 1 to 560 2 to 562 exact tiling clone, capped   561/561
(100 %)
2 diff
(99.7 %id)
DA178120 amygdala .u 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
BQ354171 head_neck .va-u 1 to 316 14 to 330 F17W I44M tiling clone,   317/330
(96 %)
6 diff
(98.2 %id)
BI035540 nervous_normal .vb-u 1 to 191 1 to 191 Y18C tiling clone,   191/191
(100 %)
5 diff
(97.4 %id)
DW442905 Liver .vd-u 1 to 165 17 to 181 exact tiling clone, AAA   165/181
(91 %)
6 diff
(96.7 %id)
AA331437 Embryo, 8 weeks Gene DHTKD1andSEC61A2, variant not shown              
AW968735   Gene DHTKD1andSEC61A2, variant not shown         This clone was ignored    
BE090952 breast Gene DHTKD1andSEC61A2, variant not shown         This clone was ignored    
BG010540 placenta_normal Gene DHTKD1andSEC61A2, variant not shown              
DB309801 hippocampus Gene DHTKD1andSEC61A2, variant not shown              
DA334242 hippocampus Gene DHTKD1andSEC61A2, variant not shown       capped      
CV355624 head_neck Gene DHTKD1andSEC61A2, variant not shown              
BX643981   Gene DHTKD1andSEC61A2, variant not shown              
T77704 liver and spleen Gene DHTKD1andSEC61A2, variant not shown         This clone was ignored    
T77882 liver and spleen Gene DHTKD1andSEC61A2, variant not shown         This clone was ignored    
W86528 liver and spleen Gene DHTKD1andSEC61A2, variant not shown         This clone was ignored    
W86672 liver and spleen Gene DHTKD1andSEC61A2, variant not shown         This clone was ignored    
AW195828 Kidney Gene DHTKD1andSEC61A2, variant not shown         Suspected internal deletion, this clone was ignored    
CB134342 Liver Gene DHTKD1andSEC61A2, variant not shown         Suspected internal deletion, this clone was ignored    
AV763496 bone marrow Gene DHTKD1andSEC61A2, variant not shown         Submitted on the opposite strand    
AU150714   Gene DHTKD1andSEC61A2, variant not shown         This clone was ignored    
AU128433   Gene DHTKD1andSEC61A2, variant not shown       capped This clone was ignored    
DB138884 thymus Gene DHTKD1andSEC61A2, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB345224 thymus Gene DHTKD1andSEC61A2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t, .u, .va-u, .vb-u, .vc-u, .vd-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI